A Phase 2 Study to Evaluate the Efficacy and Safety of VIR-2482 for the Prevention of Illness Due to Influenza A
Clinical trial NCT05567783 · TERMINATED
Trial details
- NCT number
- NCT05567783
- Sponsor
- Vir Biotechnology, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-30
- Primary completion
- 2023-05-05
- Enrollment
- 2977
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.